CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma

NCT03710421 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Plasma Cell Myeloma
Refractory Plasma Cell Myeloma

Interventions

PROCEDURE: CS1-CAR T Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Leukapheresis

Sponsor

City of Hope Medical Center

Collaborators

[object Object]